Tan Neville, Marwick Thomas H, Dey Damini, Chan William, Nerlekar Nitesh
Department of Cardiology, Western Health, Melbourne, Australia; Baker Heart and Diabetes Institute, Melbourne, Australia; Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia.
Baker Heart and Diabetes Institute, Melbourne, Australia; Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia; Menzies Institute for Medical Research, Hobart, Australia; Department of Cardiology, Royal Hobart Hospital, Hobart, Australia.
JACC Cardiovasc Imaging. 2025 Aug;18(8):884-894. doi: 10.1016/j.jcmg.2025.04.008. Epub 2025 Jul 10.
The characterization of pericoronary adipose tissue (PCAT) attenuation may provide adjunctive prognostic information to coronary evaluation at coronary computed tomography angiography. However, heterogeneity in measurement methodologies has led to uncertainties regarding its clinical applicability.
This systematic review and meta-analysis explores the impact of measurement methodology on the association between PCAT and major adverse cardiac events (MACE) and high-risk plaque (HRP).
Studies linking PCAT to MACE and HRP were searched in online databases. Quantitative meta-analysis was only performed where univariable HR estimates were reported, and random effects modelling with 95% CIs are reported. Qualitative synthesis was performed where multivariable estimates were reported.
There were 17 studies (N = 10,482) included. Quantitative analysis was performed in 8,396 patients, all with stable coronary artery disease; elevated right coronary artery (RCA)-PCAT attenuation was associated with MACE (HR: 1.22 [95% CI: 1.08-1.38]; P = 0.001), with weak significance in left circumflex-PCAT (HR: 1.03 [95% CI: 1.01-1.05]; P = 0.014), and left anterior descending artery-PCAT did not meet significance (HR: 1.01 [95% CI: 0.98-1.05]; P = 0.47). No quantitative synthesis was possible for association with HRP. Qualitatively, studies have shown a positive and significant association with RCA-PCAT and HRP (HR range: 1.03-5.62). Although studies adjusted for different risk modifiers in multivariable models, a positive association was found despite different measurement methodology (mean PCAT, fat attenuation index) and minor differences in study-defined cutoffs for elevated RCA-PCAT attenuation.
Although the strength of associations varied by measurement technique, PCAT is associated with MACE and high-risk plaque.
冠状动脉周围脂肪组织(PCAT)衰减特征可为冠状动脉计算机断层扫描血管造影术的冠状动脉评估提供辅助预后信息。然而,测量方法的异质性导致其临床适用性存在不确定性。
本系统评价和荟萃分析探讨测量方法对PCAT与主要不良心脏事件(MACE)和高危斑块(HRP)之间关联的影响。
在在线数据库中检索将PCAT与MACE和HRP相关联的研究。仅在报告单变量HR估计值时进行定量荟萃分析,并报告具有95%置信区间的随机效应模型。在报告多变量估计值时进行定性综合分析。
纳入17项研究(N = 10482)。对8396例均患有稳定冠状动脉疾病的患者进行了定量分析;右冠状动脉(RCA)-PCAT衰减升高与MACE相关(HR:1.22 [95%CI:1.08 - 1.38];P = 0.001),左旋支-PCAT有微弱显著性(HR:1.03 [95%CI:1.01 - 1.05];P = 0.014),左前降支-PCAT未达到显著性(HR:1.01 [95%CI:0.98 - 1.05];P = 0.47)。无法对与HRP的关联进行定量综合分析。定性分析表明,研究显示RCA-PCAT与HRP呈正相关且具有显著性(HR范围:1.03 - 5.62)。尽管研究在多变量模型中对不同的风险修正因素进行了调整,但尽管测量方法(平均PCAT、脂肪衰减指数)不同且研究定义的RCA-PCAT衰减升高临界值存在微小差异,仍发现呈正相关。
尽管关联强度因测量技术而异,但PCAT与MACE和高危斑块相关。